Literature DB >> 26300660

Ready or not? Lung cancer diagnosis in 2015.

K Jao1, C Labbe1, N B Leighl1.   

Abstract

Entities:  

Year:  2015        PMID： 26300660      PMCID： PMC4530807          DOI： 10.3747/co.22.2647

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  28 in total

1.  Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer.

Authors:  Kazuhiro Yasufuku; Masako Chiyo; Eitetsu Koh; Yasumitsu Moriya; Akira Iyoda; Yasuo Sekine; Kiyoshi Shibuya; Toshihiko Iizasa; Takehiko Fujisawa
Journal:  Lung Cancer       Date:  2005-09-19       Impact factor: 5.705

2.  Challenges to implementation of an epidermal growth factor receptor testing strategy for non-small-cell lung cancer in a publicly funded health care system.

Authors:  Peter M Ellis; Sunil Verma; Sandeep Sehdev; Jawaid Younus; Natasha B Leighl
Journal:  J Thorac Oncol       Date:  2013-09       Impact factor: 15.609

3.  Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer.

Authors:  Giorgio Scagliotti; Thomas Brodowicz; Frances A Shepherd; Christoph Zielinski; Johan Vansteenkiste; Christian Manegold; Lorinda Simms; Frank Fossella; Katherine Sugarman; Chandra P Belani
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

4.  First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Authors:  Benjamin J Solomon; Tony Mok; Dong-Wan Kim; Yi-Long Wu; Kazuhiko Nakagawa; Tarek Mekhail; Enriqueta Felip; Federico Cappuzzo; Jolanda Paolini; Tiziana Usari; Shrividya Iyer; Arlene Reisman; Keith D Wilner; Jennifer Tursi; Fiona Blackhall
Journal:  N Engl J Med       Date:  2014-12-04       Impact factor: 91.245

Review 5.  Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis.

Authors:  D P Steinfort; Y H Khor; R L Manser; L B Irving
Journal:  Eur Respir J       Date:  2010-08-06       Impact factor: 16.671

6.  Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Takahiro Nakajima; Kazuhiro Yasufuku; Akira Nakagawara; Hideki Kimura; Ichiro Yoshino
Journal:  Chest       Date:  2011-04-28       Impact factor: 9.410

7.  Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009.

Authors:  Keisha A Houston; S Jane Henley; Jun Li; Mary C White; Thomas B Richards
Journal:  Lung Cancer       Date:  2014-08-12       Impact factor: 5.705

Review 8.  Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?

Authors:  Lucia Kim; Ming Sound Tsao
Journal:  Eur Respir J       Date:  2014-08-07       Impact factor: 16.671

9.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Authors:  Giorgio Vittorio Scagliotti; Purvish Parikh; Joachim von Pawel; Bonne Biesma; Johan Vansteenkiste; Christian Manegold; Piotr Serwatowski; Ulrich Gatzemeier; Raghunadharao Digumarti; Mauro Zukin; Jin S Lee; Anders Mellemgaard; Keunchil Park; Shehkar Patil; Janusz Rolski; Tuncay Goksel; Filippo de Marinis; Lorinda Simms; Katherine P Sugarman; David Gandara
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

10.  Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

Authors:  David H Johnson; Louis Fehrenbacher; William F Novotny; Roy S Herbst; John J Nemunaitis; David M Jablons; Corey J Langer; Russell F DeVore; Jacques Gaudreault; Lisa A Damico; Eric Holmgren; Fairooz Kabbinavar
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544
View more
  1 in total

1.  Diagnostic patterns of non-small-cell lung cancer at Princess Margaret Cancer Centre.

Authors:  M Nadjafi; M R Sung; G D C Santos; L W Le; D M Hwang; M S Tsao; N B Leighl
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.